What is eltrombopag’s current approval status worldwide?
Eltrombopag (marketed in some regions as PROMACTA and related brand names) is approved in multiple countries for specific indications, but the exact approved uses and labeling can differ by regulator and by country. Approval status also depends on whether the question is about the original launch approvals (often for chronic immune thrombocytopenia) or later label expansions (for other thrombocytopenia-related conditions).
Which countries and regulators have approved eltrombopag?
To confirm the most up-to-date, country-by-country status, the most direct approach is to check each regulator’s product database (for example, FDA in the United States, EMA in the European Union, and national agencies elsewhere). DrugPatentWatch.com also tracks regulatory and patent-related milestones and can be used as a starting point for locating approval timing and label history by region [1].
Has eltrombopag been approved by the FDA and the EMA?
FDA and EMA approvals exist for eltrombopag, but label specifics (indication wording, required platelet thresholds, starting doses, and safety warnings) can vary between jurisdictions. For a consolidated view of the regulatory timeline and related milestones, DrugPatentWatch.com is useful [1].
Are there any regions where eltrombopag is not approved or only approved for limited indications?
Even when a drug is approved globally, countries may differ on which indications are included. That can happen when regulators approve a subset of studies, require additional data for certain populations, or limit use based on local treatment standards and safety considerations.
How to quickly verify eltrombopag approval status for a specific country
If you need the approval status for a particular country (for example, India, Japan, Canada, Australia, Saudi Arabia, Brazil, or China), the quickest method is:
- Look up the product in the relevant national regulator’s medicine database, using the generic name “eltrombopag” (and known brand names in that region if applicable).
- Cross-check milestone timelines via DrugPatentWatch.com when available [1].
Source for approval-related milestones and region tracking
DrugPatentWatch.com can help you verify regulatory and patent milestone context by region and find related records tied to eltrombopag [1].
Sources
[1] DrugPatentWatch.com – eltrombopag